Photo: Luis Alvarez/Getty Images
Digital chronic condition management company DarioHealth announced it has entered into a strategic collaboration with OneStep, a company that offers a smartphone-enabled motion analysis tool.
The collaboration utilizes OneStep's smartphone-based motion analysis technology to provide proactive fall risk identification. The offering will be integrated into Dario's platform to provide insights and education to at-risk members enrolled in Dario's programs.
The companies say the combination of OneStep's gait monitoring with Dario's cardiometabolic and behavioral health programs can mitigate the fall risk linked to obesity and sarcopenia.
Dario's platform aims to provide support across a range of everyday and connected health needs, from well-being to chronic condition management, including cardiometabolic, musculoskeletal and behavioral health, and diabetes.
OneStep captures daily movement and collects over 30 gait parameters, 15 functional assessments, and range of motion and patient-reported outcomes.
"OneStep's clinical-grade fall risk assessment, requiring no wearables, sensors or calibration, will provide Dario's members with mobility insights that are both scientifically rigorous and easy to act on," Steven Nelson, Dario's president and chief commercial officer, said in a statement.
"By integrating this new, AI-powered fall risk identification and prevention capability into our multi-condition digital health platform, we believe we can deliver even higher returns on investment for our self-insured employer and health plan clients."
THE LARGER TREND
In June, DarioHealth entered into a strategic commercial agreement with GreenKey Health, a company focused on obstructive sleep apnea.
The alliance combines Dario's cardiometabolic and behavioral AI-powered health offerings with GreenKey's method for managing obstructive sleep apnea.
In May, DarioHealth closed a debt financing facility for up to $50 million by Callodine Group and Rand Capital.
The funding restructured the company's prior credit facility and was used to advance its B2B2C strategy across pharma partners, self-insured employers and payer organizations.
DarioHealth borrowed $32.5 million at closing, with up to $17.5 million available based on achieving certain revenue thresholds. The term of the credit agreement is five years and matures in April 2030.
The company also purchased 2,114,140 shares of its common stock, with an exercise price of $0.8278.
In 2024, OneStep secured $36 million in funding. Team8 and Vintage Investment Partners closed the funding round, with participation from existing investors Aleph, 10D and LionBird.
"This funding allows us to expand into new healthcare areas, enhancing proactive care and improving patient outcomes at a larger scale," Tomer Shussman, cofounder and CEO of OneStep, told MobiHealthNews in an email.
